ClinicalTrials.Veeva

Menu

Postmarket Study of an Intraocular Lens Power Selection System

Alcon logo

Alcon

Status

Completed

Conditions

Cataract

Treatments

Other: Alcon Barrett Toric Calculator
Device: ORA with VerifEye+
Device: Acrysof® IQ Toric IOL

Study type

Interventional

Funder types

Industry

Identifiers

NCT03579433
ILX369-P001

Details and patient eligibility

About

The purpose of the study was to evaluate the visual acuity outcomes when using the Optiwave Refractive Analysis (ORA) with VerifEye+ and Barrett Toric Calculator for calculating intraocular lens (IOL) power and axis in subjects requiring cataract surgery and implanted with a toric IOL in both eyes.

Full description

Surgery was done on each eye on different days, 7 to 14 days apart. Subjects were seen for a total of 10 visits with a follow-up duration of 6 months.

Enrollment

124 patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Planned cataract surgery with IOL implantation
  • Able to comprehend and sign the informed consent form
  • Preoperative astigmatism of 0.75 to 3.00 Diopter
  • Willing and able to complete all required postoperative visits
  • Other protocol-defined inclusion criteria may apply

Exclusion criteria

  • Unclear intraocular media other than cataract
  • Pregnant or lactating
  • Presence or history of any condition or finding that makes the subject unsuitable as a candidate for cataract surgery or study participation or may confound the outcome of the study, in the opinion of the Investigator.
  • Other protocol-defined exclusion criteria may apply

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

124 participants in 2 patient groups

ORA with VerifEye+
Experimental group
Description:
First surgical eye randomly assigned to Acrysof® IQ Toric IOL and ORA with VerifEye+ or Acrysof® IQ Toric IOL and Barrett Toric Calculator, with the second surgical eye (fellow eye) assigned to the alternative group.
Treatment:
Device: Acrysof® IQ Toric IOL
Device: ORA with VerifEye+
Barrett Toric Calculator
Active Comparator group
Description:
First surgical eye randomly assigned to Acrysof® IQ Toric IOL and ORA with VerifEye+ or Acrysof® IQ Toric IOL and Barrett Toric Calculator, with the second surgical eye (fellow eye) assigned to the alternative group.
Treatment:
Device: Acrysof® IQ Toric IOL
Other: Alcon Barrett Toric Calculator

Trial documents
2

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems